Baidu
map

中国鲍曼不动杆菌感染诊治与防控专家共识2012

2012-01-08 中华医学杂志

【编者按】鲍曼不动杆菌已成为21世纪临床重要致病菌。鲍曼不动杆菌基因组研究发现其具有快速获得和传播耐药性的能力,多重耐药、广泛耐药、全耐药鲍曼不动杆菌已呈世界性流行,成为全球抗感染领域的挑战,更是目前我国最重要的“超级细菌”。由于鲍曼不动杆菌在自然环境、医院环境的广泛存在及在住院患者的多部位定植,临床医生在鲍曼不动杆菌感染的诊断、治疗和预防控制上存在诸多困惑。为提高鲍曼不动杆菌感染诊治与防控水平,

中文标题:

中国鲍曼不动杆菌感染诊治与防控专家共识2012

发布机构:

中华医学杂志

发布日期:

2012-01-08

简要介绍:

【编者按】鲍曼不动杆菌已成为21世纪临床重要致病菌。鲍曼不动杆菌基因组研究发现其具有快速获得和传播耐药性的能力,多重耐药、广泛耐药、全耐药鲍曼不动杆菌已呈世界性流行,成为全球抗感染领域的挑战,更是目前我国最重要的“超级细菌”。由于鲍曼不动杆菌在自然环境、医院环境的广泛存在及在住院患者的多部位定植,临床医生在鲍曼不动杆菌感染的诊断、治疗和预防控制上存在诸多困惑。为提高鲍曼不动杆菌感染诊治与防控水平,遏制我国鲍曼不动杆菌耐药性和感染流行的快速增长,由《中华医学杂志》组织,32位国内知名专家共同发起,12位专家执笔,邀请全国326位专家参与,历时7个多月,召开了12场专题讨论会,得到了卫生部行业基金(《临床多重耐药菌医院感染防控研究及应用》,编号201002021)的支持, 经过充分的意见搜集和讨论,最终达成了这份《中国鲍曼不动杆菌感染诊治与防控专家共识》。共识荟萃了国外鲍曼不动杆菌感染诊治与防控的最新进展,总结了我国绝大多数权威专家对于鲍曼不动杆菌感染诊治与防控的宝贵经验,是规范鲍曼不动杆菌感染诊治和防控的指导性文件。该共识的制定和提出,将对我国多重耐药菌的诊治与防控做出引领和示范,有助于改善我国鲍曼不动杆菌感染诊治与防控现状,有助于保障医疗质量和医疗安全,保障广大患者的生命安全和健康权益。原中华医学会会长、著名呼吸病专家钟南山院士在专家共识的制订过程中,给予了精心指导和极大的帮助,专门题词寄语:“合理用药,预防不动杆菌耐药”。由于鲍曼不动杆菌的自身特点,鲍曼不动杆菌感染诊治和防控仍有许多问题没有解决,需要广大专家的积极探索,积累经验和循证医学证据,不断完善专家共识。

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国鲍曼不动杆菌感染诊治与防控专家共识2012)] GetToolGuiderByIdResponse(projectId=1, id=c21461c00088a5cb, title=中国鲍曼不动杆菌感染诊治与防控专家共识2012, enTitle=, guiderFrom=, authorId=null, author=, summary=【编者按】鲍曼不动杆菌已成为21世纪临床重要致病菌。鲍曼不动杆菌基因组研究发现其具有快速获得和传播耐药性的能力,多重耐药、广泛耐药、全耐药鲍曼不动杆菌已呈世界性流行,成为全球抗感染领域的挑战,更是目前我国最重要的“超级细菌”。由于鲍曼不动杆菌在自然环境、医院环境的广泛存在及在住院患者的多部位定植,临床医生在鲍曼不动杆菌感染的诊断、治疗和预防控制上存在诸多困惑。为提高鲍曼不动杆菌感染诊治与防控水平,, cover=, journalId=null, articlesId=null, associationId=286, associationName=中华医学杂志, associationIntro=中华医学杂志 (ISSN 0376-2491, CN 11-2137/R) 创刊于中华医学会成立的1915年。作为中国卫生部中华医学会的会刊、中华医学会主办的一本医学综合性学术期刊,被国际上多个著名数据库所收录。作为周刊,其收录信息量大,栏目包括述评、专家论坛、医药卫生策略探讨、论著、综述、讲座、病例报告、临床病理讨论、专题笔谈、心理与疾病、国内外学术动态、读者来信、医学动态 、疑难病例析评、循征病例报告、 短篇论著、新技术新方法、新药与临床、临床医学影像等。, copyright=0, guiderPublishedTime=Sun Jan 08 08:00:00 CST 2012, originalUrl=http://guide.medlive.cn/guideline/2427, linkOutUrl=, content=【编者按】鲍曼不动杆菌已成为21世纪临床重要致病菌。鲍曼不动杆菌基因组研究发现其具有快速获得和传播耐药性的能力,多重耐药、广泛耐药、全耐药鲍曼不动杆菌已呈世界性流行,成为全球抗感染领域的挑战,更是目前我国最重要的“超级细菌”。由于鲍曼不动杆菌在自然环境、医院环境的广泛存在及在住院患者的多部位定植,临床医生在鲍曼不动杆菌感染的诊断、治疗和预防控制上存在诸多困惑。为提高鲍曼不动杆菌感染诊治与防控水平,遏制我国鲍曼不动杆菌耐药性和感染流行的快速增长,由《中华医学杂志》组织,32位国内知名专家共同发起,12位专家执笔,邀请全国326位专家参与,历时7个多月,召开了12场专题讨论会,得到了卫生部行业基金(《临床多重耐药菌医院感染防控研究及应用》,编号201002021)的支持, 经过充分的意见搜集和讨论,最终达成了这份《中国鲍曼不动杆菌感染诊治与防控专家共识》。共识荟萃了国外鲍曼不动杆菌感染诊治与防控的最新进展,总结了我国绝大多数权威专家对于鲍曼不动杆菌感染诊治与防控的宝贵经验,是规范鲍曼不动杆菌感染诊治和防控的指导性文件。该共识的制定和提出,将对我国多重耐药菌的诊治与防控做出引领和示范,有助于改善我国鲍曼不动杆菌感染诊治与防控现状,有助于保障医疗质量和医疗安全,保障广大患者的生命安全和健康权益。原中华医学会会长、著名呼吸病专家钟南山院士在专家共识的制订过程中,给予了精心指导和极大的帮助,专门题词寄语:“合理用药,预防不动杆菌耐药”。由于鲍曼不动杆菌的自身特点,鲍曼不动杆菌感染诊治和防控仍有许多问题没有解决,需要广大专家的积极探索,积累经验和循证医学证据,不断完善专家共识。, tagList=[TagDto(tagId=846, tagName=感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2862, appHits=228, showAppHits=2, pcHits=1418, showPcHits=1823, likes=122, shares=8, comments=4, approvalStatus=1, publishedTime=Sun Jan 08 00:00:00 CST 2012, publishedTimeString=2012-01-08, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Sun Jan 08 00:00:00 CST 2012, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 17:24:28 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国鲍曼不动杆菌感染诊治与防控专家共识2012)])
中国鲍曼不动杆菌感染诊治与防控专家共识2012
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1238738, encodeId=36631238e3819, content=了解了治疗现状,收益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3b8276461, createdName=ms6000000549484871, createdTime=Mon Aug 15 09:14:54 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974796, encodeId=4ec79e479653, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Sat Jun 19 08:32:57 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971662, encodeId=91669e166251, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Mon Jun 07 22:52:23 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167083, encodeId=25b316e083f9, content=该更新了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CCA224AA4C93885.jpg, createdBy=fe221715660, createdName=beatles, createdTime=Sat Dec 31 20:17:43 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
    2022-08-15 ms6000000549484871

    了解了治疗现状,收益匪浅。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1238738, encodeId=36631238e3819, content=了解了治疗现状,收益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3b8276461, createdName=ms6000000549484871, createdTime=Mon Aug 15 09:14:54 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974796, encodeId=4ec79e479653, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Sat Jun 19 08:32:57 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971662, encodeId=91669e166251, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Mon Jun 07 22:52:23 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167083, encodeId=25b316e083f9, content=该更新了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CCA224AA4C93885.jpg, createdBy=fe221715660, createdName=beatles, createdTime=Sat Dec 31 20:17:43 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
    2021-06-19 柏医

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1238738, encodeId=36631238e3819, content=了解了治疗现状,收益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3b8276461, createdName=ms6000000549484871, createdTime=Mon Aug 15 09:14:54 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974796, encodeId=4ec79e479653, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Sat Jun 19 08:32:57 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971662, encodeId=91669e166251, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Mon Jun 07 22:52:23 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167083, encodeId=25b316e083f9, content=该更新了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CCA224AA4C93885.jpg, createdBy=fe221715660, createdName=beatles, createdTime=Sat Dec 31 20:17:43 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
    2021-06-07 柏医

    想学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1238738, encodeId=36631238e3819, content=了解了治疗现状,收益匪浅。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0c3b8276461, createdName=ms6000000549484871, createdTime=Mon Aug 15 09:14:54 CST 2022, time=2022-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974796, encodeId=4ec79e479653, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Sat Jun 19 08:32:57 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971662, encodeId=91669e166251, content=想学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04535496017, createdName=柏医, createdTime=Mon Jun 07 22:52:23 CST 2021, time=2021-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=167083, encodeId=25b316e083f9, content=该更新了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160905/IMG57CCA224AA4C93885.jpg, createdBy=fe221715660, createdName=beatles, createdTime=Sat Dec 31 20:17:43 CST 2016, time=2016-12-31, status=1, ipAttribution=)]
    2016-12-31 beatles

    该更新了。

    0

Baidu
map
Baidu
map
Baidu
map